Mr Chris Hall was appointed as a Non-Executive Director effective 30 September 2025. As Mr Hall was nominated for appointment by Tanarra Capital, Mr Hall is not considered independent.
Chris brings to the Board extensive experience across asset management, superannuation and, recently, biotechnology. His career has included roles as Chair, Non-Executive Director and Chief Investment Officer, along with senior executive positions in Australia and Hong Kong.
Chris’ current roles include Chair of BiomeBank, Non-Executive Director, Investment Committee Member and Audit Committee Member of AMP Superannuation, Non-Executive Director and Audit Committee Member of Funds SA, Investment Committee Chair of Perks Private Wealth, Member of the Advistory Board to the Long_Term Value Fund at Tanarra Capital, Member of the Merlon Advisory Board and Member of the Research Australia Advisory Board.
Chris holds a Bachelor of Business from the University of South Australia and he has completed the Professional Management Program (MBA Program) at the University of Adelaide. He is also a member of the Australian Institute of Company Directors.